The Potential for Targeting Oncogenic WNT/&bgr; -Catenin Signaling in Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|9|7|532-547

ISSN： 1389-4501

Source： Current Drug Targets, Vol.9, Iss.7, 2008-07, pp. : 532-547

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The potential of targeting Wnt/β-catenin in colon cancer

By Sebio Ana   Kahn Michael   Lenz Heinz-Josef  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 6, 2014-06 ,pp. : 611-615

Informa Healthcare

Access to resources Recommend Favorite

Effects of Natural Compounds on Xenopus Embryogenesis: A Potential Read Out for Functional Drug Discovery Targeting Wnt/&bgr;-catenin Signaling

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 19, 2012-10 ,pp. : 2103-2113

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Wnt/ββ-catenin signaling pathway in human cancers

By Yao Hisayuki   Ashihara Eishi   Maekawa Taira  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 7, 2011-07 ,pp. : 873-887

Informa Healthcare

Access to resources Recommend Favorite

Wnt/&bgr;-Catenin/LEF-1 Signaling in Chronic Lymphocytic Leukemia (CLL): A Target for Current and Potential Therapeutic Options

By  

Current Cancer Drug Targets, Vol. 10, Iss. 7, 2010-11 ,pp. : 716-727

Bentham Science Publishers

Access to resources Recommend Favorite

Wnt/beta-Catenin Signaling and Small Molecule Inhibitors

By  

Current Pharmaceutical Design, Vol. 19, Iss. 4, 2013-02 ,pp. : 634-664

Bentham Science Publishers

Access to resources Recommend Favorite